Top Markets
#1 Pleasing Gold Pleasing Gold +1,497.26%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.63%
#4 Ontology Gas Ontology Gas +33.04%
#5 BOOK OF MEME BOOK OF MEME +29.03%
#6 ConstitutionDAO ConstitutionDAO +27.43%
#7 Collect on Fanable Collect on Fanable +24.55%
#8 Neiro Neiro +24.33%
#9 Pump.fun Pump.fun +22.47%
#10 Unit Pump Unit Pump +21.78%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
DaBomb Protein Biotech Corp. DaBomb Protein Biotech Corp.

DaBomb Protein Biotech Corp.

6578
株式のランク #26388
DaBomb Protein Biotech Corp. is a specialized biotechnology enterprise... DaBomb Protein Biotech Corp. is a specialized biotechnology enterprise primarily dedicated to developing and commercializing antibiotic replacements for the animal health industry. Its extensive product range includes plant-based proteins such as DaBomb-P (Aqua) and DaBomb-P (Livestock), alongside specific antibiotic alternative solutions like DBT-100 HT and DBT-100 LS. The company also manufactures pet care products, featuring LACTOTIDES HEALTH A+ and Liqui-TIDE bandages. Founded in 2001 and headquartered in Tainan, Taiwan, the firm adopted its current name, DaBomb Protein Biotech Corp., in October 2023, having previously operated as DaBomb Protein Corp.
株価
$0.5692026
時価総額
$40.95M
変化（1日）
-0.56%
変化（1年）
-31.16%
国
TW
取引 DaBomb Protein Biotech Corp. (6578)

カテゴリー

Consumer Defensive
DaBomb Protein Biotech Corp.（6578）の収益
Aug 2026 時点の収益 TTM: 0
DaBomb Protein Biotech Corp. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
DaBomb Protein Biotech Corp. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Nestlé S.A. Nestlé S.A.
Nestlé S.A.
NESN.SW
 $114.93B -
CH
Danone S.A. Danone S.A.
Danone S.A.
BN.PA
 - -
FR
Ajinomoto Co., Inc. Ajinomoto Co., Inc.
Ajinomoto Co., Inc.
2802.T
 - -
JP
Nestlé India Limited Nestlé India Limited
Nestlé India Limited
NESTLEIND.NS
 $2.69B -
IN
JBS S.A. JBS S.A.
JBS S.A.
JBSS3.SA
 - -
BR